Cycloastragenol improves hepatic steatosis by activating farnesoid X receptor signalling. (Q38827843)

From Wikidata
Jump to navigation Jump to search
scientific article published on 17 April 2017
edit
Language Label Description Also known as
English
Cycloastragenol improves hepatic steatosis by activating farnesoid X receptor signalling.
scientific article published on 17 April 2017

    Statements

    Cycloastragenol improves hepatic steatosis by activating farnesoid X receptor signalling (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit